Department of Nephrology, Baker IDI Heart and Diabetes Institute, Victoria, Australia.
Am J Physiol Renal Physiol. 2011 Jun;300(6):F1437-47. doi: 10.1152/ajprenal.00015.2011. Epub 2011 Mar 23.
Deficiency of the intrinsic lysosomal protein human scavenger receptor class B, member 2 (SCARB2; Limp-2 in mice) causes collapsing focal and segmental glomerular sclerosis (FSGS) and myoclonic epilepsy in humans, but patients with no apparent kidney damage have recently been described. We now demonstrate that these patients can develop tubular proteinuria. To determine the mechanism, mice deficient in Limp-2, the murine homolog of SCARB2, were studied. Most low-molecular-weight proteins filtered by the glomerulus are removed in the proximal convoluted tubule (PCT) by megalin/cubilin-dependent receptor-mediated endocytosis. Expression of megalin and cubilin was unchanged in Limp-2(-/-) mice, however, and the initial uptake of injected Alexa Fluor 555-conjugated bovine serum albumin (Alexa-BSA) was similar to wild-type mice, indicating that megalin/cubilin-dependent, receptor-mediated endocytosis was unaffected. There was a defect in proteolysis of reabsorbed proteins in the Limp-2(-/-) mice, demonstrated by the persistence of Alexa-BSA in the PCT compared with controls. This was associated with the failure of the lysosomal protease cathepsin B to colocalize with Alexa-BSA and endogenous retinol-binding protein in kidneys from Limp-2(-/-) mice. The data suggest that tubular proteinuria in Limp-2(-/-) mice is due to failure of endosomes containing reabsorbed proteins to fuse with lysosomes in the proximal tubule of the kidney. Failure of proteolysis is a novel mechanism for tubular proteinuria.
人源清道夫受体 B 类成员 2(SCARB2;在小鼠中称为 Limp-2)内在溶酶体蛋白的缺乏会导致人类局灶性和节段性肾小球硬化症(FSGS)和肌阵挛性癫痫,但最近描述了没有明显肾脏损伤的患者。我们现在证明这些患者可能会发生管状蛋白尿。为了确定机制,研究了缺乏 Limp-2 的小鼠,Limp-2 是 SCARB2 的鼠类同源物。大多数由肾小球滤过的低分子量蛋白质在近端曲管(PCT)中通过巨球蛋白/穹窿蛋白依赖性受体介导的内吞作用被去除。然而,Limp-2(-/-) 小鼠中巨球蛋白和穹窿蛋白的表达没有改变,并且注射的 Alexa Fluor 555 结合牛血清白蛋白(Alexa-BSA)的初始摄取与野生型小鼠相似,表明巨球蛋白/穹窿蛋白依赖性受体介导的内吞作用没有受到影响。Limp-2(-/-) 小鼠中再吸收蛋白的蛋白水解存在缺陷,与对照组相比,PCT 中 Alexa-BSA 的持续存在证明了这一点。这与溶酶体蛋白酶组织蛋白酶 B 未能与 Limp-2(-/-) 小鼠肾脏中的 Alexa-BSA 和内源性视黄醇结合蛋白共定位有关。数据表明,Limp-2(-/-) 小鼠的管状蛋白尿是由于再吸收蛋白的内体未能与肾脏近端小管中的溶酶体融合所致。蛋白酶水解的失败是管状蛋白尿的一种新机制。